Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/HCV-coinfected patients
To assess the possible association between the use of direct antiviral agents (DAA) and the risk of hepatocellular carcinoma (HCC) in HIV/HCV-coinfected patients. The GEHEP-002 cohort recruits HCC cases in HIV-infected patients from 32 centers from Spain. Three analyses were performed: thSee it on Scoop.it, via Viruses, Immunology & Bioinformatics from Virology.uvic.ca
Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/HCV-coinfected patients
Source: Viral Bioinformatics
